While GLP-1 primarily supports appetite control, GIP enhances insulin sensitivity, improves how the body utilizes energy, and supports healthier fat metabolism
Jrgens, B
, stable in human gastric juice more than 24 hours, and use without carrier (otherwise, peptide + carrier(s) -complex bears considerable methodological/activity dilemmas), prominent antiulcer effect, and a safe application in inflammatory bowel disease patients with improved wound/intestinal anastomosis healing, adhesion prevention, collagen deposition, and anastomotic strength, along with prominent effect in cuprizone rats ( i.e
Its FDA approval came in 1982, and its efficacy is not in question only whether its side effect profile is acceptable for a given patient
Researchers suggest that this could be due to the drugs causing malabsorption of folate, increasing excretion of folate in urine, and accelerating folate metabolism